The Clorox Company (NYSE:CLX) Shares Sold by Apeiron RIA LLC

Apeiron RIA LLC reduced its stake in shares of The Clorox Company (NYSE:CLX) by 51.2% during the 4th quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The fund owned 1,648 shares of the company’s stock after selling 1,728 shares during the period. Apeiron RIA LLC’s holdings in Clorox were worth $268,000 as of its most recent SEC filing.

Other large investors have also made changes to their positions in the company. Sei Investments Co. increased its position in Clorox by 0.5% during the second quarter. Sei Investments Co. now owns 92,305 shares of the company’s stock worth $12,598,000 after purchasing an additional 468 shares during the last quarter. Thrivent Financial for Lutherans increased its holdings in shares of Clorox by 8.7% during the 2nd quarter. Thrivent Financial for Lutherans now owns 8,855 shares of the company’s stock worth $1,208,000 after buying an additional 709 shares during the last quarter. Public Sector Pension Investment Board raised its position in shares of Clorox by 75.6% during the 2nd quarter. Public Sector Pension Investment Board now owns 4,775 shares of the company’s stock valued at $652,000 after buying an additional 2,055 shares during the period. Marshall Wace LLP acquired a new position in Clorox in the second quarter valued at approximately $5,672,000. Finally, BRITISH COLUMBIA INVESTMENT MANAGEMENT Corp grew its position in Clorox by 60.5% in the second quarter. BRITISH COLUMBIA INVESTMENT MANAGEMENT Corp now owns 23,769 shares of the company’s stock worth $3,244,000 after acquiring an additional 8,957 shares during the period. 78.53% of the stock is currently owned by hedge funds and other institutional investors.

Analysts Set New Price Targets

Several brokerages have recently commented on CLX. JPMorgan Chase & Co. upped their price target on Clorox from $167.00 to $171.00 and gave the company a “neutral” rating in a research note on Thursday, January 16th. Barclays lowered their target price on shares of Clorox from $139.00 to $130.00 and set an “underweight” rating for the company in a research note on Friday, January 17th. Jefferies Financial Group raised shares of Clorox from a “hold” rating to a “buy” rating and boosted their price target for the company from $174.00 to $187.00 in a research note on Tuesday, October 1st. Wells Fargo & Company raised shares of Clorox from an “underweight” rating to an “equal weight” rating and increased their price objective for the stock from $155.00 to $157.00 in a research report on Tuesday, January 7th. Finally, TD Cowen raised Clorox from a “sell” rating to a “hold” rating and boosted their target price for the company from $155.00 to $170.00 in a research report on Wednesday, November 6th. Four analysts have rated the stock with a sell rating, ten have issued a hold rating and one has issued a buy rating to the company’s stock. According to data from MarketBeat, the stock presently has an average rating of “Hold” and an average target price of $156.54.

Clorox Stock Performance

Shares of CLX opened at $159.12 on Friday. The Clorox Company has a 1 year low of $127.60 and a 1 year high of $171.37. The stock has a market capitalization of $19.70 billion, a PE ratio of 55.44, a PEG ratio of 2.92 and a beta of 0.42. The company has a debt-to-equity ratio of 11.08, a quick ratio of 0.62 and a current ratio of 1.00. The stock has a 50-day simple moving average of $163.83 and a 200-day simple moving average of $157.13.

Clorox (NYSE:CLX) last issued its quarterly earnings results on Wednesday, October 30th. The company reported $1.86 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $1.36 by $0.50. Clorox had a net margin of 4.78% and a return on equity of 316.08%. The company had revenue of $1.76 billion during the quarter, compared to the consensus estimate of $1.64 billion. During the same quarter in the previous year, the firm earned $0.49 earnings per share. The firm’s quarterly revenue was up 27.0% on a year-over-year basis. On average, analysts predict that The Clorox Company will post 6.87 earnings per share for the current fiscal year.

Clorox Dividend Announcement

The firm also recently declared a quarterly dividend, which will be paid on Friday, February 14th. Shareholders of record on Wednesday, January 29th will be paid a $1.22 dividend. This represents a $4.88 dividend on an annualized basis and a yield of 3.07%. The ex-dividend date of this dividend is Wednesday, January 29th. Clorox’s dividend payout ratio is presently 170.03%.

Clorox Company Profile

The Clorox Company manufactures and markets consumer and professional products worldwide. It operates through four segments: Health and Wellness, Household, Lifestyle, and International. The Health and Wellness segment offers cleaning products, such as laundry additives and home care products primarily under the Clorox, Clorox2, Scentiva, Pine-Sol, Liquid-Plumr, Tilex, and Formula 409 brands; professional cleaning and disinfecting products under the CloroxPro and Clorox Healthcare brands; professional food service products under the Hidden Valley brand; and vitamins, minerals and supplement products under the RenewLife, Natural Vitality, NeoCell, and Rainbow Light brands in the United States.